SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer

Human Molecular Genetics

Volumn 17, Issue 7, 2008, Pages 1031-1042

  Dong, Xue Yuan ^a   Rodriguez, Carmen ^b   Guo, Peng ^a   Sun, Xiaodong ^a   Talbot, Jeffrey T ^b   Zhou, Wei ^a   Petros, John ^a,c   Li, Qunna ^a   Vessella, Robert L ^d   Kibel, Adam S ^e   Stevens, Victoria L ^b   Calle, Eugenia E ^b   Dong, Jin Tang ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; SMALL NUCLEOLAR RNA;

ADULT; AGED; ARTICLE; BASE PAIRING; CANCER CELL CULTURE; CASE CONTROL STUDY; CELL STRAIN LNCAP; CHROMOSOME 6Q; CHROMOSOME DELETION; CHROMOSOME DELETION 6; COHORT ANALYSIS; COLONY FORMATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT;

BASE SEQUENCE; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 6; COHORT STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RECESSIVE; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; HOMOZYGOTE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RNA, SMALL NUCLEOLAR; SEQUENCE DELETION;

EID: 41149126821     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm375     Document Type: Article

References (33)

1. Scardino, P.T., Weaver, R. and Hudson, M.A. (1992) Early detection of prostate cancer. Hum. Pathol., 23, 211-222.
2. Sakr, W.A., Grignon, D.J., Crissman, J.D., Heilbrun, L.K., Cassin, B.J., Pontes, J.J. and Haas, G.P. (1994) High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma bctween the ages of 20-69: An autopsy study of 249 cases. In Vivo, 8, 439-443.
3. Postma, R. and. Schroder, F.H. (2005) Screening for prostate cancer. Eur. J. Cancer, 41, 825-833.
4. McGregor, M., Hanley, J.A., Boivin, J.F. and McLean, R.G. (1998) Screening for prostate cancer: Estimating the magnitude of overdetection. Can. Med. Assoc. J., 159, 1368-1372.
5. Knuutila, S., Aalto, Y., Autio, K., Bjorkqvist, A.M., El-Rifai, W., Hemmer, S., Huhta, T., Kettunen, E., Kiura-Kuhlefelt, S., Larramendy, M.L. et al. (1999) DNA copy number losses in human neoplasms. Am. J. Pathol., 155, 683-694.
6. Dong, J.T. (2001) Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev., 20, 173-193.
7. Trent, J.M., Stanbridge, E.J., McBride, H.L., Meese, E.U., Casey, G., Araujo, D.E., Witkowski, C.M. and Nagle, R.B. (1990) Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science, 247, 568-571.
8. Welch, D.R., Chen, P., Miele, M.E., McGary, C.T., Bower, J.M., Stanbridge, E.J. and Weissman, B.E. (1994) Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene, 9, 255-262.
9. Sandhu, A.K., Kaur, G.P., Reddy, D.E., Rane, N.S. and Athwal, R.S. (1996) A gene on 6q 14-21 restores genescence to immortal ovarian tumor cells. Oncogene, 12, 247-252.
10. Theile, M., Seitz, S., Arnold, W., Jandrig, B., Frege, R., Schlag, P.M., Haensch, W., Guski, M., Winzer, K.J., Barrett, J.C. et al. (1996) A defined chromosome 6q fragment (at D6S3 10) harbors a putative tumor suppressor gene for breast cancer. Oncogene, 13, 677-685.
11. Morelli, C., Cardona, F., Boyle, J.M., Negrini, M. and Barbanti-Brodano, G. (1997) Mapping of 22 new ESTs around a tumor suppressor gene and a senescence gene at 6q16- > q2 1. Cytogene Cell Genet., 79, 97-100.
12. Miele, M.E., Jewett, M.D., Goldberg, S.F., Hyatt, D.L., Morelli, C., Gudlandi, F., Rimessi, P., Hicks, D.J., Weissman, B.E., Barbanti-Brodano, G. et al. (2000) A human melanoma metastasis-suppressor locus maps to 6q16.3-q23. Int. J. Cancer, 86, 524-528.
13. Sun, X., Frierson, H.F., Chen, C., Li, C., Ran, Q., Otto, K.B., Cantarel, B.L., Vessella, R.L., Gao, A.C., Petros, J. et al. (2005) Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. Nat. Genet., 37, 407-412.
14. Tanaka, R., Satoh, H., Moriyama, M., Satoh, K., Morishita, Y., Yoshida, S., Watanabe, T., Nakamura, Y. and Mori, S. (2000) Intronic U50 small-nucleolar-RNA (snoRNA) host gene of no protein-coding potential is mapped at the chromosome breakpoint t(3;6)(q27;q15) of human B-cell lymphoma. Genes Cells, 5, 277-287.
15. Sun, X., Chen, C., Vessella, R.L. and Dong, J.T. (2006) Microsatellite instability and mismatch repair target gene mutations in cell lines and xenografts of prostate cancer. Prostate, 76, 660-666.
16. Levine, R.L., Wadleigh, M., Cools, J., Ebert, B.L., Wernig, G., Huntly, B.J., Moore, S. Boggon, T. J., Wlodarska, I., Clark, J.J., Moore, S. et al. (2005) Activating mutation in the tyrosine kinase in polycythemia vera, essential thrombocyhemia, and myeloid metaplasia with myelofibrosis. Cancer Cell, 7, 387-397.
17. James, C., Ugo, V., Le Couedic, J.P., Staerk, J., Delhommeau, F., Lacout, C., Garcon, L., Raslova, H., Berger, R., Bennaceur-Griscelli, A. et al. (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature, 434 1144-1148.
18. Calle, E.E., Rodriguez, C., Jacobs, E.J., Almon, M.L., Chao, A., McCullough, M.L., Feigelson, H.S. and Thun, M.J. (2002) The American Cancer Society Cancer Prevention Study II Nutrition Cohort: Rationale, study design, and baseline characteristics. Cancer, 94, 2490-2501.
19. Patel, A.V., Calle, E.E., Pavluck, A.L., Feigelson, H.S., Thun, M.J. and Rodriguez, C. (2005) A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk. Breast Cancer Res., 7, R1168-R1173.
20. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R. et al. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275, 1943-1947.
21. Liu, W., Chang, B.L., Cramer, S., Koty, P.P., Li, T., Sun, J., Turner, A.R., Von Kap-Herr, C., Bobby, P., Rao, J. et al. (2007) Deletion of a small consensus region at 6q15, including the MAP3K7 gene, is significantly associated with high-grade prostate cancers. Clin. Cancer Res., 13, 5028-5033.
22. Knudson, A.G., Jr (1977) Genetics and etiology of human cancer. Adv. Hum. Genet., 8, 1-66.
23. Mattick, J.S. and Makunin, I.V. (2005) Small regulatory RNAs in mammals. Hum. Mol. Genet., 14, R121-R132.
24. Kishore, S. and Stamm, S. (2006) The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science, 311 230-232.
25. Kiss, T. (2002) Small nucleolar RNAs: An abundant group of noncoding RNAs with diverse cellular functions. Cell, 109, 145-148.
26. Cavaille, J., Buiting, K., Kiefmann, M., Lalande, M., Brannan, C.I., Horsthemke, B., Bachellerie, J.P., Brosius, J. and Huttenhofer, A. (2000) Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization. Proc. Natl Acad Sci. USA, 97, 14311-14316.
27. Chang, L.S., Lin, S.Y., Lieu, A.S. and Wu, T.L. (2002) Differential expression of human 5S snoRNA genes. Biochem. Biophys. Res. Commun. 299, 196-200.
28. Donsante, A., Miller, D.G., Li, Y., Vogler, C., Brunt, E.M., Russell, D.W. and Sands, M.S. (2007) AAV vector integration sites in mouse hepatocellular carcinoma. Science, 317, 477.
29. Schneider, C., King, R.M. and Philipson, L. (1988) Genes specifically expressed at growth arrest of mammalian cells. Cell, 54, 787-793.
30. Smith, C.M. and Steitz, J.A. (1998) Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5′-terminal oligopyrimidine gene family reveals common features of snoRNA host genes. Mol. Cell Biol., 18, 6897-6909.
31. Cho, S., Park, S.M., Kim, T.D., Kim, J.H., Kim, K.T. and Jang, S.K. (2007) BiP internal ribosomal entry site activity is controlled by heat-induced interaction of NSAP1. Mol. Cell Biol., 27, 368-383.
32. Zhi, X., Chen, S., Zhou, P., Shao, Z., Wang, L., Ou, Z. and Yin, L. (2007) RNA interference of ecto-5′-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion. Clin. Exp. Metastasis, 24, 439-448.
33. Dong, X.Y., Chen, C., Sun, X., Guo, P., Vessella, R.L., Wang, R.X., Chung, L.W., Zhou, W. and Dong, J.T. (2006) FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signalling in prostate cancer. Cancer Res., 66, 6998-7006.